Cormorant Private Healthcare Fund III LP
CIK 1817320 · last filed 2025-06-13
Cormorant Private Healthcare Fund III LP is a corporate insider who has filed 6 SEC Form 4 insider transactions across 5 companies since 2021. The most recent filing, for BMEA, was dated Jun 13, 2025. Across all open-market trades the lifetime net is +$410.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $57.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$57.72M
5
6
$410.80M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BMEA | 10%+ Owner | 3,570,872 | $1.17 | $4.18M | $0 | 1 | 2025-06-13 |
| Ambrx Biopharma Inc. (AMAM) Delisted | 10%+ Owner | 65,474,542 | $28.00 | $1.83B | $276.65M | 2 | 2023-04-20 |
| Verve Therapeutics, Inc. (VERV) Delisted | 984,224 | $11.13 | $10.95M | $20.90M | 1 | 2021-06-23 | |
| RAIN | 2,776,657 | $2.04 | $5.66M | $38.25M | 1 | 2021-04-29 | |
| DSGN | 4,364,844 | $10.97 | $47.88M | $75.00M | 1 | 2021-04-01 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-13 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2023-04-20 | Ambrx Biopharma Inc. (AMAM) Delisted | Buy (P) | +20,860,756 | $235.80M | EDGAR |
| 2023-03-16 | Ambrx Biopharma Inc. (AMAM) Delisted | Buy (P) | +4,000,000 | $40.85M | EDGAR |
| 2021-06-23 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | +3,936,896 | $20.90M | EDGAR |
| 2021-04-29 | RAIN | Mixed | +13,883,285 | $38.25M | EDGAR |
| 2021-04-01 | DSGN | Mixed | +25,574,220 | $75.00M | EDGAR |